Study reveals racial disparities in Huntington’s disease diagnoses

New research led by UCLA Health revealed that Black patients with Huntington’s disease in the U.S. and Canada received their diagnoses, on average, one year later compared to White patients after symptoms first appear.

Hahn Awarded CZI Grant to Monitor, Manipulate Proteins Important in Nervous System Function, Neurological Disease

Klaus Hahn, PhD, the Ronald G. Thurman Distinguished Professor of Pharmacology at the UNC School of Medicine, will co-lead this Chan Zuckerberg Initiative project with colleagues at Duke University and North Carolina State University.

‘Carb’ Treatment for Stroke Receives New U.S. Patent

A new twist on a drug used to treat alcohol use disorder could double up as a treatment for stroke. Called “Carb” for short, this new formulation is designed to treat ischemic stroke, protect brain tissue against injury and minimize the size of a brain infarct.

University of Washington joins industry-academia alliance to accelerate research in neuroscience

The University of Washington has joined the Alliance for Therapies in Neuroscience (ATN), a long-term research partnership between UC San Francisco, UC Berkeley, Genentech (a member of the Roche group) and Roche Holding AG geared to transform the fight against brain diseases and disorders of the central nervous system.

‘Eye-catching’ smartphone app could make it easy to screen for neurological disease at home

UC San Diego researchers developed a smartphone app that could allow people to screen for Alzheimer’s disease, ADHD and other neurological diseases and disorders—by recording closeups of their eye. The app uses a smartphone’s built-in near-infrared camera and selfie camera to track how a person’s pupil changes in size. These pupil measurements could be used to assess a person’s cognitive condition.

Microvention Funds $250,000 Educational Grant for the Advancement of Endovascular Education and Technology to the CNS Foundation

MicroVention, one of the world’s fastest growing medical device companies, has granted $250,000 to the Congress of Neurological Surgeons Foundation (CNS Foundation). This generous gift will fund educational programs dedicated toward the advancement of the field of endovascular education and technology.